Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial (Q34614245)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial (English)

1 reference

Europe PubMed Central

3 August 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neoadjuvant chemotherapy

1 reference

based on heuristic

inferred from title

Claus-Henning Köhne

18

object named as

Claus-Henning Köhne

0 references

10

object named as

Jürgen Weitz

1 reference

Europe PubMed Central

3 August 2017

Wolf Otto Bechstein

3

object named as

Wolf O Bechstein

1 reference

Europe PubMed Central

3 August 2017

Jan Stoehlmacher

9

object named as

Jan Stoehlmacher

1 reference

Europe PubMed Central

3 August 2017

Torsten Liersch

13

object named as

Torsten Liersch

1 reference

Europe PubMed Central

3 August 2017

7

object named as

Hauke Lang

1 reference

Europe PubMed Central

3 August 2017

Christian Stroszczynski

12

object named as

Christian Stroszczynski

1 reference

Europe PubMed Central

3 August 2017

Thomas Gruenberger

2

object named as

Thomas Gruenberger

1 reference

Europe PubMed Central

3 August 2017

author name string

Gunnar Folprecht

1

1 reference

Europe PubMed Central

3 August 2017

Hans-Rudolf Raab

4

1 reference

Europe PubMed Central

3 August 2017

Florian Lordick

5

1 reference

Europe PubMed Central

3 August 2017

Jörg T Hartmann

6

1 reference

Europe PubMed Central

3 August 2017

Andrea Frilling

8

1 reference

Europe PubMed Central

3 August 2017

Ralf Konopke

11

1 reference

Europe PubMed Central

3 August 2017

Detlev Ockert

14

1 reference

Europe PubMed Central

3 August 2017

Thomas Herrmann

15

1 reference

Europe PubMed Central

3 August 2017

Eray Goekkurt

16

1 reference

Europe PubMed Central

3 August 2017

Fabio Parisi

17

1 reference

Europe PubMed Central

3 August 2017

publication date

26 November 2009

1 reference

Europe PubMed Central

3 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

3 August 2017

11

1 reference

Europe PubMed Central

3 August 2017

1

1 reference

Europe PubMed Central

3 August 2017

38-47

1 reference

Europe PubMed Central

3 August 2017

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic variables for resection of colorectal cancer hepatic metastases: an evolving paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of margins on outcome after hepatic resection for colorectal metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970330-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(09)70330-4

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34614245&oldid=2113311471"